In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.

Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically ...

Drug development and commercialization leads to tremendous advances in medicine and improvements to everyday life, but it often comes at a cost. Delayed clinical trials, regulatory approvals, and ...

Oct. 20 (UPI) --Anthropic on Monday announced a new service called Claude of Life Sciences that uses artificial intelligence in efforts to advance scientific discovery. This is the San Francisco-based ...

Process validation is crucial for ensuring the quality of final products and the safety of these processes for manufacturing personnel and consumers in the pharmaceutical, medical device, and ...